You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1359 NTX-0471, engineered multivalent SIRPa and bispecific SIRPa-antiCCR4 molecules demonstrate superior activity providing path for mRNA expressed in-vivo biologics

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1359 NTX-0471, engineered multivalent SIRPa and bispecific SIRPa-antiCCR4 molecules demonstrate superior activity providing path for mRNA expressed in-vivo biologics

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023258024
Dec 202370013
Jan 202413306
Feb 202446012
Mar 20247407
Apr 202466014
May 20246508
Jun 20245308
Jul 20249106
Aug 2024143011
Sep 20244805
Oct 202454015
Nov 20244008
Dec 202450012
Jan 20254809
Feb 20251406
Mar 2025008
Apr 2025007
May 2025008
Jun 2025203
Total12550190